Key Takeaways
- Moderna (MRNA) announced the US FDA has accepted its Biologics License Application for mRNA-1010, a seasonal influenza vaccine, with a PDUFA goal date of August 5, 2026.
- Ukraine is actively seeking a leaders-level dialogue with China to discuss peace efforts, according to Foreign Ministry spokesperson Heorhii Tykhyi.
- Kyiv and Beijing are currently planning ministry-level meetings to facilitate deeper bilateral engagement and address regional security issues.
- Moderna’s (MRNA) revised regulatory strategy seeks full approval for adults aged 50-64 and accelerated approval for those 65 and older.
- Shares of Moderna (MRNA) rose approximately 2% in early trading following the FDA's decision to proceed with the review.
The US Food and Drug Administration (FDA) has officially initiated its review of Moderna's (MRNA) investigational seasonal influenza vaccine, mRNA-1010. This milestone follows a Type A meeting where the company proposed a revised regulatory pathway after previously receiving a refusal-to-file letter. The FDA has set a Prescription Drug User Fee Act (PDUFA) action date for August 5, 2026, positioning the vaccine for potential availability during the 2026/2027 flu season.
Moderna (MRNA) is seeking full approval for adults aged 50 to 64 and accelerated approval for those 65 and older, the latter of which would require a post-marketing study. Investors reacted positively to the news, as the acceptance of the application signals a significant step in Moderna's effort to diversify its mRNA portfolio beyond COVID-19. The vaccine is also currently under regulatory review in Europe, Canada, and Australia.
On the geopolitical front, Ukraine is intensifying its diplomatic outreach to China, expressing a strong interest in a leaders-level dialogue. Ukrainian Foreign Ministry spokesperson Heorhii Tykhyi confirmed on Wednesday that the government is working toward a high-profile meeting between President Volodymyr Zelenskyy and Chinese leader Xi Jinping. This push for top-tier engagement follows recent discussions at the Munich Security Conference where both nations signaled that the "door to dialogue" remains open.
In the immediate term, Ukraine and China are planning a series of ministry-level meetings to lay the groundwork for further cooperation. Tykhyi emphasized that a direct dialogue with Beijing is "very important," particularly regarding the implementation of a just peace and the protection of territorial integrity. Diplomatic analysts suggest that Kyiv is looking to leverage China's influence to pressure Russia toward a negotiated settlement as the conflict enters its fourth year.
The planned meetings between foreign ministry officials are expected to cover a broad range of bilateral and regional international issues. Ukraine has also extended an invitation to Chinese Foreign Minister Wang Yi to visit the country to witness the impact of the ongoing war firsthand. While a specific timeline for a presidential summit has not been finalized, the move toward ministry-level talks indicates a dynamic intensification of relations between the two capitals.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.